Robert Horne was named senior vice president of operations atTSI Corp. He was vice president of chemical, pharmaceuticaland health care markets at Digital Equipment Corp. Worcester,Mass.-based TSI (NASDAQ:TSIN) offers in vitro and in vivopreclinical and toxicology testing services, human clinicaltesting services and diagnostic intermediate products.

Burroughs Wellcome Co. of Triangle Park, N.C., named MarkPerrin vice president of research. He was vice president andgeneral manager at Lederle Pharmaceuticals. Burroughs, aresearch-based pharmaceutical company, is a wholly ownedsubsidiary of The Wellcome Foundation Ltd of London.

Cephalon Inc. of West Chester, Pa., promoted Michael E. Lewisto senior director of scientific affairs. He co-founded thecompany and had been director of pharmacology since 1987.Cephalon (NASDAQ:CEPH) is focusing on the development ofproducts to treat neurodegenerative diseases.

PerSeptive Biosystems Inc. of Cambridge, Mass., named RobertAnacone senior vice president of marketing and sales. He wasvice president of worldwide marketing and sales at SeronoDiagnostics Inc. PerSeptive (NASDAQ:PBIO) manufactures andmarkets proprietary products and systems for the purificationand analysis of biomolecules.

Collagen Corp. named Barry Calvarese director of regulatoryaffairs. He was director of scientific and regulatory affairs atAdvanced Surgical Intervention Inc. Collagen (NASDAQ:CGEN) ofPalo Alto, Calif., develops, manufactures and marketsbiomedical devices for treating defective, diseased, traumatizedor aging human tissues, and specialized catheter systems fortreating neurovascular disorders.

David Okrongly was named vice president of advancedapplications technology at Applied Immune Sciences Inc.(NASDAQ:AISX). The Menlo, Calif., company is developing exvivo cell therapy for AIDS, cancer and bone marrowtransplantation.

Protein Design Labs Inc. of Mountain View, Calif., named BrentR. Larsen director of process development. He was a seniorscientist at Genentech Inc. PDL (NASDAQ:PDLI) is engaged inthe computer-based design of antibodies and other novelproteins to treat various diseases.

The Bangladesh Society of Microbiologists recently honored RitaColwell, president of the Maryland Biotech. Institute, with anhonorary life membership in recognition of her contributions tothe field of microbiology and her dedication to trainingBangladeshi microbiologists.

Dale Mehl, former director of marketing at Weitek, has beennamed director of marketing at BioCAD Corp. The MountainView, Calif., company develops desktop software to helpvisualize, generate and test chemical ideas.

Roberts Pharmaceutical Corp. CEO and Chairman RobertVukovick has been named New Jersey LifeScience/Biotechnology Entrepreneur of the year. He wasselected from a field of 65 nominees. In 1991, Roberts reportedrecord revenues of $14.2 million.

Philip Whitcome, president and CEO of Neurogen Corp., hasbeen named to the board at TargeTech Inc. The Meriden, Conn.,company is developing and commercializing injectable genetherapies based on its novel receptor-targeting technology.

(c) 1997 American Health Consultants. All rights reserved.